Fernandez Ruiz, Javier javier.fernandezr@uam.es

Publications

δ9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens

  • Bonnin A
  • Fernández-Ruiz JJ
  • Martín M
  • Rodríguez de Fonseca F
  • Hernández ML
  • Ramos JA

JOURNAL OF NEURAL TRANSMISSION (p. 81-95) - 1/6/1993

10.1007/bf01244868 View at source

  • ISSN 03009564

Δ9-Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB1 receptors

  • Palomares B
  • Garrido-Rodriguez M
  • Gonzalo-Consuegra C
  • Gómez-Cañas M
  • Saen-oon S
  • Soliva R
  • Collado JA
  • Fernández-Ruiz J
  • Morello G
  • Calzado MA
  • Appendino G
  • Muñoz E
... View more Collapse

BRITISH JOURNAL OF PHARMACOLOGY (p. 4034-4054) - 1/9/2020

10.1111/bph.15155 View at source

  • ISSN 00071188

delta 9-Tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons

  • Hernandez, M L
  • Garcia-Gil, L
  • Berrendero, F
  • Ramos, J A
  • Fernandez-Ruiz, J J

JOURNAL OF MOLECULAR NEUROSCIENCE (p. 83-91) - 1/1/1997

10.1007/bf02736775 View at source

  • ISSN 08958696

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways

  • del Rio C
  • Cantarero I
  • Palomares B
  • Gómez-Cañas M
  • Fernández-Ruiz J
  • Pavicic C
  • García-Martín A
  • Luz Bellido M
  • Ortega-Castro R
  • Pérez-Sánchez C
  • López-Pedrera C
  • Appendino G
  • Calzado M
  • Muñoz E
... View more Collapse

BRITISH JOURNAL OF PHARMACOLOGY (p. 3813-3831) - 1/10/2018

10.1111/bph.14450 View at source

  • ISSN 00071188

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease

  • Díaz-Alonso J
  • Paraíso-Luna J
  • Navarrete C
  • Del Río C
  • Cantarero I
  • Palomares B
  • Aguareles J
  • Fernández-Ruiz J
  • Bellido M
  • Pollastro F
  • Appendino G
  • Calzado M
  • Galve-Roperh I
  • Muñoz E
... View more Collapse

Scientific Reports - 19/7/2016

10.1038/srep29789 View at source

  • ISSN 20452322

Upregulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis

  • Fernandez-Trapero M
  • Espejo-Porras F
  • Rodriguez-Cueto C
  • Coates J
  • Perez-Diaz C
  • De Lago E
  • Fernandez-Ruiz J
... View more Collapse

Disease Models & Mechanisms (p. 551-558) - 1/5/2017

10.1242/dmm.028373 View at source

  • ISSN 17548403

University students' strategies and criteria during self-assessment: instructor's feedback, rubrics, and year level effects

  • Panadero, Ernesto
  • García-Pérez, Daniel
  • Fernández Ruiz, Javier
  • Fraile, Juan
  • Sánchez Iglesias, Iván
  • T L Brown, Gavin

European Journal Of Psychology Of Education (p. 1031-1051) - 24/10/2022

10.1007/s10212-022-00639-4 View at source

  • ISSN 02562928

Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen

  • Romero J
  • Berrendero F
  • Pérez-Rosado A
  • Manzanares J
  • Rojo A
  • Fernández-Ruiz JJ
  • De Yebenes JG
  • Ramos JA
... View more Collapse

Life Sciences (p. 485-494) - 31/12/1999

10.1016/s0024-3205(99)00618-9 View at source

  • ISSN 00243205

UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders

  • De Lago E
  • Fernández-Ruiz J
  • Ortega-Gutiérrez S
  • Cabranes A
  • Pryce G
  • Baker D
  • López-Rodríguez M
  • Ramos JA
... View more Collapse

EUROPEAN NEUROPSYCHOPHARMACOLOGY (p. 7-18) - 1/1/2006

10.1016/j.euroneuro.2005.06.001 View at source

  • ISSN 0924977X

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide

  • De Lago E
  • Fernández-Ruiz J
  • Ortega-Gutiérrez S
  • Viso A
  • López-Rodríguez ML
  • Ramos JA

EUROPEAN JOURNAL OF PHARMACOLOGY (p. 99-103) - 2/8/2002

10.1016/s0014-2999(02)01996-9 View at source

  • ISSN 00142999

This researcher has no books.

The service of Minors' Guardian Officers in Madrid Municipal Police

  • Javier Fernández Ruiz

Memoria Del Congreso International Sobre Seguridad Ciudadana En La Sociedad Diversa: 19 A 22 De Octubre De 2011 (p. 370-371) - 1/1/2011

  • iMarina

The endocannabinoid system in the physiology and pathology of the basal ganglia

  • Gerdeman G
  • Fernández-Ruiz J

Cannabinoids and the Brain (p. 423-483) - 1/1/2008

10.1007/978-0-387-74349-3_21 View at source

Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies

  • Fernández-Ruiz J
  • Gómez-Ruiz M
  • García C
  • Hernández M
  • Ramos JA

Methods In Enzymology (p. 175-198) - 1/1/2017

10.1016/bs.mie.2017.06.021 View at source

  • ISSN 00766879

La protección de menores en la Policía Municipal de Madrid

  • Javier Fernández Ruiz

El derecho a la protección de los niños y niñas en la Comunidad de Madrid (p. 171-180) - 1/1/2010

  • iMarina

Endocannabinoids and amyotrophic lateral sclerosis

  • de Lago E
  • Moreno-Martet M
  • Espejo-Porras F
  • Fernández-Ruiz J

Cannabinoids in Neurologic and Mental Disease (p. 99-123) - 21/1/2015

10.1016/b978-0-12-417041-4.00005-9 View at source

Endocannabinoids and Neurodegenerative disorders: Parkinson’s disease, Huntington’s chorea, Alzheimer’s disease, and others

  • Fernández-Ruiz J
  • Romero J
  • Ramos J

Handbook of Experimental Pharmacology (p. 233-259) - 29/9/2015

10.1007/978-3-319-20825-1_8 View at source

  • ISSN 01712004

Endocannabinoid-Binding Receptors as Drug Targets

  • Gómez-Cañas M
  • Rodríguez-Cueto C
  • Satta V
  • Hernández-Fisac I
  • Navarro E
  • Fernández-Ruiz J

Methods In Molecular Biology (p. 67-94) - 1/1/2023

10.1007/978-1-0716-2728-0_6 View at source

  • ISSN 10643745

Chapter 2: Phytocannabinoids Versus Endocannabinoids. A Modern View of the Endocannabinoid System

  • Fernández-Ruiz J
  • Sagredo O
  • De Lago E

RSC Drug Discovery Series (p. 10-47) - 1/1/2021

10.1039/9781839160752-00010 View at source

  • ISSN 20413203

Cannabinoids and the brain: New hopes for new therapies

  • Fernández-Ruiz J
  • Hernández M
  • García-Movellán Y

Cannabinoids (p. 175-218) - 11/8/2014

10.1002/9781118451281.ch6 View at source

Effects of neonatal exposure to methamphetamine: Catecholamine levels in brain areas of the developing rat

  • Gomes-Da-Silva J
  • De Miguel R
  • Fernández-Ruiz J
  • Summavielle T
  • Tavares M

Annals of the New York Academy of Sciences (p. 602-611) - 1/1/2004

10.1196/annals.1316.075 View at source

  • ISSN 00778923

Disentangling self-assessment

  • Panadero, E. & Fernández-Ruiz, J

29/8/2018

  • iMarina

Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors

  • López-Rodríguez ML
  • Viso A
  • Ortega-Gutiérrez S
  • Fowler CJ
  • Tiger G
  • De Lago E
  • Fernández-Ruiz J
  • Ramos JA
... View more Collapse

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (p. 403-412) - 1/4/2003

10.1016/s0223-5234(03)00045-x View at source

  • ISSN 02235234

Cannabinoid tolerance and dependence: A review of studies in laboratory animals

  • González S
  • Cebeira M
  • Fernández-Ruiz J

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (p. 300-318) - 1/1/2005

10.1016/j.pbb.2005.01.028 View at source

  • ISSN 00913057

This researcher has no working papers.

This researcher has no technical reports.

This researcher has no research projects.

This researcher has no supervised thesis.

This researcher has no patents or software licenses.

Last data update: 3/18/24 11:57 PM